Ipilimumab vs Memantine

## Ipilimumab vs Memantine: Overview

This comparison examines the pharmacological differences between **Ipilimumab** and **Memantine**.

## Mechanism of Action

**Ipilimumab**: Fully human anti-CTLA-4 IgG1 monoclonal antibody that blocks CTLA-4 inhibitory signaling.

**Memantine**: Non-competitive NMDA receptor antagonist.

## Pharmacokinetics

**Half-life**: Ipilimumab — 14.7 days; Memantine — 60-80 hours.

## Chemical Properties

**Molecular Formula**: Ipilimumab — N/A; Memantine — C12H21N.

**Molecular Weight**: Ipilimumab — N/A; Memantine — 179.3080 g/mol.

**Type**: Ipilimumab — Antibody; Memantine — Small molecule.